Image of a woman with headphones on a laptop to show Winning pharma brands: Changing the rules of a market

Winning pharma brands: Changing the rules of a market

Understanding the bigger questions that winning pharma brands ask to change the market and redefine the playing field. The global health emergency that we are...
Image of a laptop, phone, glasses, pen, ad, cup of coffee and person with their hand on the mouse to show Pf's new webinar series on Pharma and Integrated Care Systems: How to make your brand relevant

Pf Webinars: Pharma and Integrated Care Systems – How to make your brand relevant

Pf is proud to announce a new FREE webinar series with Triducive. The first webinar, focuses on pharma and integrated care systems. In this...
Business conversation: contracting market access activities

Why are life science companies contracting market access activities?

Sathyanarayanan Krishnamurthy, Vice President – Regulatory Operations at Freyr Solutions looks at contracting out market access activities and how this frees up life sciences...
Image of four people communicating via different mediums to depict mind the Generation Gap in pharma marketing

Mind the generation gap in pharma marketing and market research

Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Magnus Franzen on customer experience management

The art of customer experience management (CXM)

Magnus Franzen explains why customer experience management is essential to delivering what your customers need. Customer experience management (CXM) is both a discipline and a philosophy. “ACROSS...
Image of target with people holding arrows and graphs in the background to show New research initiative to tackle multimorbidity - applications required

The key to engaging healthcare professionals effectively

Hank Sczerba on how to understand healthcare professionals in order to target them more effectively Tell me about yourself and what you do? I am Head...
Thinking outside of the box: sales insight using AI

Improve your sales insight using AI

Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
Pill packet uk popped out. The impact of Brexit on the regulatory and marketing landscape

The impact of Brexit on the regulatory and marketing landscape

Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
Graphic illustration of hand putting pound coin into moneybox with heart and cross on outside with two pills lying next to it to show NHS financial management and sustainability

HFMA’s Chris Calkin on how the money in the NHS system works

How does the money flow through the NHS? Here’s the inside intelligence. The complicated structure of the NHS is often impenetrable, even to those who...

Latest articles

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, has just launched its largest grants programme to date, the 2021 Small...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
New COVID-19 test reduces testing time from 30 minutes to five

New COVID-19 test reduces testing time from 30 minutes to five

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription